Skip to content

Clinical trials

Enrolling by invitation Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Enrolling by invitation Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20201
20211
20234
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Azienda Ospedaliero, Universitaria Pisana1
Ellen Margrethe Hauge1
Gene Solutions1
Harvard Medical School (HMS and HSDM)1
Icahn School of Medicine at Mount Sinai1
National Cancer Institute (NCI)1
Peking University People's Hospital1
Region Skane1
Shanghai Pulmonary Hospital, Shanghai, China1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms15
Pulmonary Disease, Chronic Obstructive4
Carcinoma, Non-Small-Cell Lung3
Disease3
Anxiety Disorders2
Arthritis, Rheumatoid2
Brain Neoplasms2
Breast Neoplasms2
Cardiovascular Diseases2
Colonic Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.